JP2010507649A5 - - Google Patents

Download PDF

Info

Publication number
JP2010507649A5
JP2010507649A5 JP2009534060A JP2009534060A JP2010507649A5 JP 2010507649 A5 JP2010507649 A5 JP 2010507649A5 JP 2009534060 A JP2009534060 A JP 2009534060A JP 2009534060 A JP2009534060 A JP 2009534060A JP 2010507649 A5 JP2010507649 A5 JP 2010507649A5
Authority
JP
Japan
Prior art keywords
fungi
jewelry
medicine
allergies
medicament according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009534060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010507649A (ja
Filing date
Publication date
Priority claimed from IT000583A external-priority patent/ITRM20060583A1/it
Application filed filed Critical
Publication of JP2010507649A publication Critical patent/JP2010507649A/ja
Publication of JP2010507649A5 publication Critical patent/JP2010507649A5/ja
Pending legal-status Critical Current

Links

JP2009534060A 2006-10-27 2007-09-27 アレルギーの予防及び治療のための医薬を調製するためにサイモシンアルファ1の使用 Pending JP2010507649A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000583A ITRM20060583A1 (it) 2006-10-27 2006-10-27 Uso della timosina alfa 1 per la preparazione di un medicamento per la prevenzione e la cura delle allergie
PCT/IT2007/000676 WO2008050362A2 (en) 2006-10-27 2007-09-27 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies

Publications (2)

Publication Number Publication Date
JP2010507649A JP2010507649A (ja) 2010-03-11
JP2010507649A5 true JP2010507649A5 (https=) 2010-11-11

Family

ID=39322638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009534060A Pending JP2010507649A (ja) 2006-10-27 2007-09-27 アレルギーの予防及び治療のための医薬を調製するためにサイモシンアルファ1の使用

Country Status (13)

Country Link
US (1) US20090270594A1 (https=)
EP (1) EP2083847A2 (https=)
JP (1) JP2010507649A (https=)
KR (1) KR20090092267A (https=)
CN (1) CN101626778A (https=)
AU (1) AU2007310415A1 (https=)
BR (1) BRPI0718019A2 (https=)
CA (1) CA2666562A1 (https=)
EA (1) EA200900603A1 (https=)
IL (1) IL198290A0 (https=)
IT (1) ITRM20060583A1 (https=)
MX (1) MX2009004237A (https=)
WO (1) WO2008050362A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
AR020102A1 (es) * 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
US20060121029A1 (en) * 2002-08-30 2006-06-08 Hiroshi Shiku Method and composition for regulating the activity of regulatory t cells
DK1613340T3 (da) * 2003-03-28 2010-08-30 Sciclone Pharmaceuticals Inc Behandling af aspergillus-infektioner med thymosin alfa 1

Similar Documents

Publication Publication Date Title
IL222880A (en) Peptides and their use in the treatment and diagnosis of diseases and pharmaceutical preparations containing them
DE602004017510D1 (de) Medizinprodukt vom kapseltyp
EP3682875A3 (en) Methods of treating pediatric metabolic syndrome
IL189500A (en) 4, 2-Diaminopyrimidines are preserved in position 5, containing pharmaceutical preparations and using them to prepare a drug for the treatment of 3x2p receptor mediated diseases and 2/3 x2p
EP2630864A3 (en) Antimicrobial compositions and related methods of use.
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
JP2007523135A5 (https=)
ATE464890T1 (de) Eine pharmazeutische zusammensetzung zur behandlung von pathologien, die durch die allgemeine immunantwort verursacht werden
Giri et al. Bioactive marine peptides: Nutraceutical value and novel approaches
JP2007238598A5 (https=)
EP1935418A4 (en) Composition for relieving subjective symptoms of fatigue
JP2010507649A5 (https=)
JP2009514901A5 (https=)
EP2891496A4 (en) A PHARMACEUTICAL COMPOSITION COMPRISING A COMPLEX EXTRACT FROM AURANTII NOBILIS PERICARPIUM AND CRATAEGUS AS AN ACTIVE AGENT FOR THE TREATMENT OR PREVENTION OF ADIPOSITAS OR LIPID-DERIVED METABOLISM DISEASES
JP2008539169A5 (https=)
JP2010526884A5 (https=)
JP2006342148A5 (https=)
ATE463225T1 (de) Körper- oder schönheitspflegemittel
JP2006160721A5 (https=)
JP2011121885A5 (https=)
JP2008540603A5 (https=)
JP2007529478A5 (https=)
WO2012033348A3 (ko) 2-리놀레오일 글리세롤을 포함하는 알러지성 질환의 예방 또는 치료용 조성물
TH151327A (th) องค์ประกอบและวิธีสำหรับลดไตรกลีเซอไรด์โดยไม่ทำให้ระดับldl-c เพิ่มขึ้นในผู้ป่วยที่ทำการรักษาแบบร่วมกับสเททิน